Comparison of pre-treatment with OCPs or estradiol valerate vs. no pre-treatment prior to GnRH antagonist used for IVF cycles: An RCT

BACKGROUND: Both oral contraceptive pills (OCPs) and estradiol valerate (E2) have been used to schedule a gonadotropin-releasing hormone antagonist in vitro fertilization (IVF) cycles. Since the suppression of follicle-stimulating hormone by OCPs can stay 5-7 days after stopping the pills, it seems...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Reprod Biomed
Main Authors: Shahrokh Tehrani Nejad, Ensieh, Bakhtiari Ghaleh, Fatemeh, Eslami, Bita, Haghollahi, Fedyeh, Bagheri, Maryam, Masoumi, Masoumeh
Formato: Artigo
Idioma:Inglês
Publicado em: Research and Clinical Center for Infertility 2018
Assuntos:
Short Communication
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6163045/
https://ncbi.nlm.nih.gov/pubmed/30288488
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados